These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 10803326)

  • 1. Apparent pokeweed mitogen cure of metastatic gum melanoma in an older dog.
    Wimer BM; Mann PL
    Cancer Biother Radiopharm; 2000 Apr; 15(2):201-5. PubMed ID: 10803326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PHA for aplastic anemias: the alpha but not the omega of mitogen therapies.
    Wimer BM
    Cancer Biother Radiopharm; 1998 Apr; 13(2):109-20. PubMed ID: 10850347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitogen immunotherapy for HIV infections exemplified by phytohemagglutinin and pokeweed mitogen.
    Wimer BM; Mann PL
    Cancer Biother Radiopharm; 2000 Dec; 15(6):629-44. PubMed ID: 11190495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitogen therapy for biological warfare/terrorist attacks and viral hemorrhagic fever control.
    Wimer BM
    Cancer Biother Radiopharm; 2002 Feb; 17(1):19-28. PubMed ID: 11915170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiotherapy of oral malignant melanomas in dogs.
    Blackwood L; Dobson JM
    J Am Vet Med Assoc; 1996 Jul; 209(1):98-102. PubMed ID: 8926220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What is your diagnosis? Gingival mass in a dog.
    Kerr ME; Burgess HJ
    Vet Clin Pathol; 2013 Mar; 42(1):115-6. PubMed ID: 23095107
    [No Abstract]   [Full Text] [Related]  

  • 7. Inhalation chemotherapy for macroscopic primary or metastatic lung tumors: proof of principle using dogs with spontaneously occurring tumors as a model.
    Hershey AE; Kurzman ID; Forrest LJ; Bohling CA; Stonerook M; Placke ME; Imondi AR; Vail DM
    Clin Cancer Res; 1999 Sep; 5(9):2653-9. PubMed ID: 10499645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Malignant anterior uveal melanoma with diffuse metastasis in a dog.
    Minami T; Patnaik AK
    J Am Vet Med Assoc; 1992 Dec; 201(12):1894-6. PubMed ID: 1483910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV-induced immunodeficiency. Relatively preserved phytohemagglutinin as opposed to decreased pokeweed mitogen responses may be due to possibly preserved responses via CD2/phytohemagglutinin pathway.
    Hofmann B; Jakobsen KD; Odum N; Dickmeiss E; Platz P; Ryder LP; Pedersen C; Mathiesen L; Bygbjerg IB; Faber V
    J Immunol; 1989 Mar; 142(6):1874-80. PubMed ID: 2564029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical response after intradermal immature dendritic cell vaccination in metastatic melanoma is associated with immune response to particulate antigen.
    Smithers M; O'Connell K; MacFadyen S; Chambers M; Greenwood K; Boyce A; Abdul-Jabbar I; Barker K; Grimmett K; Walpole E; Thomas R
    Cancer Immunol Immunother; 2003 Jan; 52(1):41-52. PubMed ID: 12536239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metastatic cancer of unknown primary in 21 dogs.
    Rossi F; Aresu L; Vignoli M; Buracco P; Bettini G; Ferro S; Gattino F; Ghiani F; Costantino R; Ressel L; Bellei E; Marconato L
    Vet Comp Oncol; 2015 Mar; 13(1):11-9. PubMed ID: 23295011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic immunostimulating effects of plant mitogens exemplified by the L4 isolectin of PHA.
    Wimer BM
    Cancer Biother Radiopharm; 1997 Jun; 12(3):195-212. PubMed ID: 10851466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Active specific immunotherapy for melanoma: phase I trial of allogeneic lysates and a novel adjuvant.
    Mitchell MS; Kan-Mitchell J; Kempf RA; Harel W; Shau HY; Lind S
    Cancer Res; 1988 Oct; 48(20):5883-93. PubMed ID: 3262416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitogens for curative therapy of HIV-1 infections; an update.
    Wimer BM
    Cancer Biother Radiopharm; 2002 Apr; 17(2):175-82. PubMed ID: 12030111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficient adenovector CD40 ligand immunotherapy of canine malignant melanoma.
    von Euler H; Sadeghi A; Carlsson B; Rivera P; Loskog A; Segall T; Korsgren O; Tötterman TH
    J Immunother; 2008 May; 31(4):377-84. PubMed ID: 18391758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two phenotypically distinct suppressor T cell subpopulations inhibit the induction of B cell differentiation by phytohemagglutinin.
    Clement LT; Dagg MK; Lehmeyer JE; Kiyotaki M
    J Immunol; 1983 Sep; 131(3):1214-7. PubMed ID: 6224852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gingival osteogenic melanoma in two dogs.
    Ellis AE; Harmon BG; Miller DL; Northrup NC; Latimer KS; Uhl EW
    J Vet Diagn Invest; 2010 Jan; 22(1):147-51. PubMed ID: 20093707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Malignant ameloblastic fibro-odontoma in a dog.
    Ueki H; Sumi A; Takaishi H; Ito H; Oyamada T; Yoshikawa H
    Vet Pathol; 2004 Mar; 41(2):183-5. PubMed ID: 15017034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resection and adjuvant immunotherapy for melanoma metastatic to the lung and thorax.
    Tafra L; Dale PS; Wanek LA; Ramming KP; Morton DL
    J Thorac Cardiovasc Surg; 1995 Jul; 110(1):119-28; discussion 129. PubMed ID: 7609535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjuvant therapy for melanoma in dogs: results of randomized clinical trials using surgery, liposome-encapsulated muramyl tripeptide, and granulocyte macrophage colony-stimulating factor.
    MacEwen EG; Kurzman ID; Vail DM; Dubielzig RR; Everlith K; Madewell BR; Rodriguez CO; Phillips B; Zwahlen CH; Obradovich J; Rosenthal RC; Fox LE; Rosenberg M; Henry C; Fidel J
    Clin Cancer Res; 1999 Dec; 5(12):4249-58. PubMed ID: 10632367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.